From The Daily Scan: St. Paul’s Hospital researcher receives $3.5 million for COVID-19 drug trial
Submitted by Communications & Public Affairs, Providence Health Care
A research team based at St. Paul’s Hospital has received new federal funding to continue investigating the effect of an existing class of drug on COVID-19.
Led by Dr. James Russell, a Principal Investigator at the Centre for Heart Lung Innovation, the team just received $3.5 million from the Canadian Institutes of Health Research (CIHR) for a multi-site clinical trial to study the safety and effectiveness of Losartan – a drug commonly prescribed for high blood pressure and diabetes – to treat COVID-19.
ALSO IN THIS ISSUE
- Holy Family COVID-19 Outbreak Update
- Today's Updates: June 25, 2020
- Updated Hours for COVID-19 Assessment Site on West 33rd
- Parking update for staff
- From The Daily Scan: How to wear your mask properly during COVID-19
- From The Daily Scan: Indigenous Canadians help change kidney care for their communities
- PHC Relax Rooms at The Burrard Hotel available until June 30
- Supporting staff through COVID-19
- Summer staycation ideas
- Introducing the Indigenous Wellness & Reconciliation (IWR) Working Group
- Presenting the 2020 PHC Professional Practice Recognition Awards
- Did you see the latest simulated phishing exercise -- Healthy Technologies Manufacturing - Invoice & Contract Proposal?
- Providence in the news